Back to Companies
Attovia Therapeutics, Inc.
ATTONasdaqCIK: 0002058707
Over the 35 most recent insider filings, Attovia Therapeutics, Inc. (ATTO) has seen activity from 18 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $72.9M bought versus $9.0M sold, a net purchase of $63.9M. WALSH COLIN (Director) is the most active by dollar volume, and the single largest transaction was $12.5M by WALSH COLIN. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$101.5M
Purchases
$72.9M
Sales
$9.0M
Unique Insiders
18
Recent Insider Trades
35 loaded
| Aug 10 | ATTO Attovia Therapeutics, Inc. | Deep Track Biotechnology Master Fund, Ltd. | Insider | Conversion | $0 |
| Aug 7 | ATTO Attovia Therapeutics, Inc. | Sanofi | Insider | Buy | $5.1M |
| Aug 10 | ATTO Attovia Therapeutics, Inc. | venBio Global Strategic Fund IV, L.P. | Insider | Buy | $6.5M |
| Aug 6 | ATTO Attovia Therapeutics, Inc. | Frazier Life Sciences XI, L.P. | Insider | Buy | $10.0M |
| Aug 7 | ATTO Attovia Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Buy | $10.2M |
| Aug 13 | ATTO Attovia Therapeutics, Inc. | WALSH COLIN | Director | Buy | $10.3M |
| Aug 28 | ATTO Attovia Therapeutics, Inc. | WALSH COLIN | Director | Buy | $10.3M |
| Aug 28 | ATTO Attovia Therapeutics, Inc. | GOLDMAN SACHS GROUP INC | Insider | Buy | $10.3M |
| Aug 13 | ATTO Attovia Therapeutics, Inc. | GOLDMAN SACHS GROUP INC | Insider | Buy | $10.3M |
| Aug 6 | ATTO Attovia Therapeutics, Inc. | You Angie | Insider | Award | $459.0K |
| Aug 5 | ATTO Attovia Therapeutics, Inc. | WALSH COLIN | Director | Other | $0 |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Sanofi | Insider | Other | $0 |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Vida Ventures GP III, L.L.C. | Insider | Other | $0 |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Topper James N | Insider | Other | $0 |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | GOLDMAN SACHS GROUP INC | 10% Owner | Other | $0 |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | You Angie | Insider | Other | $0 |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Attovia Therapeutics, Inc. | Insider | Other | $0 |
| Aug 5 | ATTO Attovia Therapeutics, Inc. | Alamar HoldCo, LLC | Insider | Other | $0 |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Odrowaz Zaneta | Insider | Other | $0 |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | venBio Global Strategic Fund IV, L.P. | Insider | Other | $0 |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Veiby Petter | Insider | Other | $0 |
| Aug 6 | ATTO Attovia Therapeutics, Inc. | Attovia Therapeutics, Inc. | Insider | Award | $2.4M |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Chen Hubert | Insider | Other | $0 |
| Aug 6 | ATTO Attovia Therapeutics, Inc. | Veiby Petter | Insider | Award | $2.4M |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Deep Track Biotechnology Master Fund, Ltd. | Insider | Other | $0 |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Smither John W | Insider | Other | $0 |
| Aug 6 | ATTO Attovia Therapeutics, Inc. | Odrowaz Zaneta | Insider | Award | $2.4M |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Frazier Life Sciences XI, L.P. | Insider | Other | $0 |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Other | $0 |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | GOLD MITCHELL | Insider | Other | $0 |
| Aug 6 | ATTO Attovia Therapeutics, Inc. | Chen Hubert | Insider | Award | $2.4M |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Royston Aaron | Insider | Other | $0 |
| Aug 4 | ATTO Attovia Therapeutics, Inc. | Attovia Therapeutics, Inc. | Insider | Other | $0 |
| Aug 6 | ATTO Attovia Therapeutics, Inc. | GOLD MITCHELL | Insider | Award | $459.0K |
| Aug 6 | ATTO Attovia Therapeutics, Inc. | Attovia Therapeutics, Inc. | Insider | Award | $9.2M |
35 filings